These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 34368172)

  • 1. Use of Psychotropic "Pro Re Nata" Medications by Patients Attending the Outpatient Clinic in a Hospital: A Qualitative Exploration.
    Rajiah K; Maharajan MK; Ramaya H; Wan Ab Rahman WNA
    Front Med (Lausanne); 2021; 8():617147. PubMed ID: 34368172
    [No Abstract]   [Full Text] [Related]  

  • 2.
    Saito E; Eng S; Grosso C; Ozinci Z; Van Meter A
    J Child Adolesc Psychopharmacol; 2020 May; 30(4):250-260. PubMed ID: 31800304
    [No Abstract]   [Full Text] [Related]  

  • 3. PRN Medicines Management for Psychotropic Medicines in Long-Term Care Settings: A Systematic Review.
    Vaismoradi M; Vizcaya Moreno F; Sletvold H; Jordan S
    Pharmacy (Basel); 2019 Nov; 7(4):. PubMed ID: 31775262
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The characteristics of discharge prescriptions including pro re nata psychotropic medications for patients with schizophrenia and major depressive disorder from the survey of the "Effectiveness of guidelines for dissemination and education in psychiatric treatment (EGUIDE)" project.
    Kyou Y; Yasui-Furukori N; Hasegawa N; Ide K; Ichihashi K; Hashimoto N; Hori H; Shimizu Y; Imamura Y; Muraoka H; Iida H; Ohi K; Yasuda Y; Ogasawara K; Numata S; Iga JI; Tsuboi T; Ochi S; Kodaka F; Furihata R; Onitsuka T; Makinodan M; Komatsu H; Takeshima M; Kubota C; Hishimoto A; Atake K; Yamagata H; Kido M; Nagasawa T; Usami M; Kishimoto T; Kikuchi S; Matsumoto J; Miura K; Yamada H; Watanabe K; Inada K; Hahimoto R
    Ann Gen Psychiatry; 2022 Dec; 21(1):52. PubMed ID: 36567327
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pro re nata medication for psychiatric inpatients: time to act.
    Hilton MF; Whiteford HA
    Aust N Z J Psychiatry; 2008 Jul; 42(7):555-64. PubMed ID: 18612858
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pro re nata medication for psychoses: an audit of practice in two metropolitan hospitals.
    Geffen J; Sorensen L; Stokes J; Cameron A; Roberts MS; Geffen L
    Aust N Z J Psychiatry; 2002 Oct; 36(5):649-56. PubMed ID: 12225449
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of Psychotropic
    Kyou Y; Oishi S; Takizawa T; Yoshimura Y; Hashimoto I; Suzuki R; Demizu R; Ono T; Noguchi Y; Kimura T; Inada K; Miyaoka H
    Clin Psychopharmacol Neurosci; 2023 May; 21(2):332-339. PubMed ID: 37119226
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The characteristics of patients receiving psychotropic pro re nata medication at discharge for the treatment of schizophrenia and major depressive disorder: A nationwide survey from the EGUIDE project.
    Ichihashi K; Kyou Y; Hasegawa N; Yasui-Furukori N; Shimizu Y; Hori H; Hashimoto N; Ide K; Imamura Y; Yamada H; Ochi S; Iga JI; Takaesu Y; Ohi K; Tsuboi T; Iida H; Yamagata H; Hishimoto A; Horai T; Usami M; Makinodan M; Nagasawa T; Komatsu H; Kido M; Muraoka H; Atake K; Takeshima M; Kubota C; Inagaki T; Tamai S; Kishimoto T; Furihata R; Matsumoto J; Miura K; Inada K; Watanabe K; Kasai K; Hashimoto R
    Asian J Psychiatr; 2022 Mar; 69():103007. PubMed ID: 35051727
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Patient participation in pro re nata medication in forensic psychiatric care: A nursing document analysis.
    Hipp K; Repo-Tiihonen E; Kuosmanen L; Katajisto J; Kangasniemi M
    J Psychiatr Ment Health Nurs; 2021 Aug; 28(4):611-621. PubMed ID: 33085793
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The impact of a good practice manual on professional practice associated with psychotropic PRN in acute mental health wards: an exploratory study.
    Baker JA; Lovell K; Harris N
    Int J Nurs Stud; 2008 Oct; 45(10):1403-10. PubMed ID: 18313059
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Descriptive analysis of pro re nata medication use at a Canadian psychiatric hospital.
    Martin K; Arora V; Fischler I; Tremblay R
    Int J Ment Health Nurs; 2017 Aug; 26(4):402-408. PubMed ID: 27804222
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A best-evidence synthesis review of the administration of psychotropic pro re nata (PRN) medication in in-patient mental health settings.
    Baker JA; Lovell K; Harris N
    J Clin Nurs; 2008 May; 17(9):1122-31. PubMed ID: 18416789
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pro re nata medication for psychoses: the knowledge and beliefs of doctors and nurses.
    Geffen J; Cameron A; Sorensen L; Stokes J; Roberts MS; Geffen L
    Aust N Z J Psychiatry; 2002 Oct; 36(5):642-8. PubMed ID: 12225448
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Administration of
    Jimu M; Doyle L
    Issues Ment Health Nurs; 2019 Jun; 40(6):511-517. PubMed ID: 30917088
    [No Abstract]   [Full Text] [Related]  

  • 15. Experiences of mental health professionals and patients in the use of pro re nata medication in acute adult mental healthcare settings: a systematic review.
    Morkunas B; Porritt K; Stephenson M
    JBI Database System Rev Implement Rep; 2016 Oct; 14(10):209-250. PubMed ID: 27846125
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pro re nata (as needed) psychotropic medication use in patients with borderline personality disorder and subjects with other personality disorders over 14 years of prospective follow-up.
    Martinho E; Fitzmaurice GM; Frankenburg FR; Zanarini MC
    J Clin Psychopharmacol; 2014 Aug; 34(4):499-503. PubMed ID: 24875066
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rates of PRN Medication Administration in Australian Residential Aged Care.
    Picton L; Ilomäki J; Keen CS; Lalic S; Adams B; Clinnick LM; Kirkpatrick CM; Ryan-Atwood T; Turner JP; Bell JS
    J Am Med Dir Assoc; 2021 Jan; 22(1):117-123.e1. PubMed ID: 32611523
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Patient participation in pro re nata medication in psychiatric inpatient settings: An integrative review.
    Hipp K; Kuosmanen L; Repo-Tiihonen E; Leinonen M; Louheranta O; Kangasniemi M
    Int J Ment Health Nurs; 2018 Apr; 27(2):536-554. PubMed ID: 29271033
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Documentation of psychotropic pro re nata medication administration: An evaluation of electronic health records compared with paper charts and verbal reports.
    Martin K; Ham E; Hilton NZ
    J Clin Nurs; 2018 Aug; 27(15-16):3171-3178. PubMed ID: 29752835
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Frequency of and factors related to pro re nata (PRN) medication use in aged care services.
    Stasinopoulos J; Bell JS; Ryan-Atwood TE; Tan ECK; Ilomäki J; Cooper T; Robson L; Sluggett JK
    Res Social Adm Pharm; 2018 Oct; 14(10):964-967. PubMed ID: 29158071
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.